Last reviewed · How we verify
Tazarotene Cream 0.05%
Tazarotene Cream 0.05% is a retinoid Small molecule drug developed by Fougera Pharmaceuticals Inc.. It is currently in Phase 3 development for Acne, Psoriasis. Also known as: Tazarotene.
Tazarotene is a topical retinoid that modulates cell growth and differentiation.
Tazarotene is a topical retinoid that modulates cell growth and differentiation. Used for Acne, Psoriasis.
At a glance
| Generic name | Tazarotene Cream 0.05% |
|---|---|
| Also known as | Tazarotene |
| Sponsor | Fougera Pharmaceuticals Inc. |
| Drug class | retinoid |
| Target | retinoic acid receptor |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
It works by binding to retinoic acid receptors, which are involved in regulating cell growth and differentiation. This leads to an increase in cell turnover and a decrease in the appearance of fine wrinkles and skin discoloration.
Approved indications
- Acne
- Psoriasis
Common side effects
- Skin irritation
- Dry skin
- Redness
Key clinical trials
- Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis (PHASE4)
- Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis (PHASE2)
- A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis (PHASE3)
- Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis (PHASE3)
- Sorafenib-induced Hand- Foot Skin Reaction Treatment (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tazarotene Cream 0.05% CI brief — competitive landscape report
- Tazarotene Cream 0.05% updates RSS · CI watch RSS
- Fougera Pharmaceuticals Inc. portfolio CI
Frequently asked questions about Tazarotene Cream 0.05%
What is Tazarotene Cream 0.05%?
How does Tazarotene Cream 0.05% work?
What is Tazarotene Cream 0.05% used for?
Who makes Tazarotene Cream 0.05%?
Is Tazarotene Cream 0.05% also known as anything else?
What drug class is Tazarotene Cream 0.05% in?
What development phase is Tazarotene Cream 0.05% in?
What are the side effects of Tazarotene Cream 0.05%?
What does Tazarotene Cream 0.05% target?
Related
- Drug class: All retinoid drugs
- Target: All drugs targeting retinoic acid receptor
- Manufacturer: Fougera Pharmaceuticals Inc. — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Acne
- Indication: Drugs for Psoriasis
- Also known as: Tazarotene
- Compare: Tazarotene Cream 0.05% vs similar drugs
- Pricing: Tazarotene Cream 0.05% cost, discount & access